A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors.

被引：0
|
作者：
Kristeleit, Rebecca Sophie
Shapiro, Geoffrey
LoRusso, Patricia
Infante, Jeffrey R.
Flynn, Michael
Patel, Manish R.
Tolaney, Sara M.
Hilton, John Frederick
Calvert, Alan Hilary
Giordano, Heidi
Isaacson, Jeffrey D.
Borrow, Jennifer
Allen, Andrew R.
Jaw-Tsai, Sarah S.
Burris, Howard A.
机构：
[1] UCL, London, England
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[4] Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA
[5] Florida Canc Specialists, Sarah Cannon Res Inst, Sarasota, FL USA
[6] Clovis Oncol Inc, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2585
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I dose-escalation and pk study of continuous oral rucaparib in patients with advanced solid tumors
    Flynn, M.
    Shapiro, G.
    LoRusso, P.
    Kristeleit, R.
    Patel, M.
    Infante, J.
    Giordano, H.
    Borrow, J.
    Jaw-Tsai, S.
    Burris, H., III
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S185 - S185
  • [2] Phase I dose-escalation study of pasireotide LAR in patients with advanced neuroendocrine tumors.
    Phan, Alexandria T.
    Wolin, Edward M.
    Chan, Jennifer A.
    Huang, Jerry M.
    Hudson, Michelle
    Hughes, Gareth
    Shen, Guoxiang
    Strosberg, Jonathan R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A phase I dose-escalation study of IMGN388 in patients with solid tumors.
    Thompson, D. S.
    Patnaik, A.
    Bendell, J. C.
    Papadopoulos, K.
    Infante, J. R.
    Mastico, R. A.
    Johnson, D.
    Qin, A.
    O'Leary, J. J.
    Tolcher, A. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase I dose-escalation study of continuous oral treatment with the angiokinase inhibitor BIBF 1120 in patients with advanced solid tumors
    Kaneda, H.
    Okamoto, I.
    Satoh, T.
    Arao, T.
    Nishio, K.
    Sarashina, A.
    Konishi, K.
    Stopfer, P.
    Kaiser, R.
    Nakagawa, K.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 133 - 133
  • [5] A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumors.
    Berlin, Jordan
    Ramanathan, Ramesh K.
    Strickler, John H.
    Subramaniam, Deeps Suresh
    Hurwitz, Herbert
    Kang, Yoon-Koo
    Kim, Tae-You
    Shepherd, Stacie Peacock
    Xiong, Hao
    Hetman, Robert
    Nickner, Caroline
    Dudley, Matthew W.
    Giranda, Vincent L.
    Lenz, Heinz-Josef
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
    Cao, Junning
    Ji, Dongmei
    Chen, Zhiyu
    Shen, Weina
    Wang, Jin
    Li, Baoyue
    Chi, Haidong
    Long, Amanda
    Gao, Ling
    Li, Jin
    [J]. ONCOLOGIST, 2017, 22 (06): : 638 - +
  • [7] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [8] Phase I, dose-escalation study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced solid tumors.
    Adjei, Alex A.
    LoRusso, Patricia
    Ribas, Antoni
    Sosman, Jeffrey Alan
    Pavlick, Anna C.
    Dy, Grace K.
    Zhou, Xiaofei
    Gangolli, Esha A.
    Walker, Russell M.
    Kneissl, Michelle
    Faucette, Stephanie
    Neuwirth, Rachel
    Bozon, Viviana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
    Padda, Sukhmani K.
    Krupitskaya, Yelena
    Chhatwani, Laveena
    Fisher, George A.
    Colevas, Alexander D.
    Pedro-Salcedo, Melanie San
    Decker, Rodney
    Latz, Jane E.
    Wakelee, Heather A.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1013 - 1020
  • [10] Phase I/Ib dose-escalation study of aveluma in Chinese patients with advanced solid tumors
    Wu, Yi-Long
    Cheng, Ying
    Chen, Huajun
    Tu, Haiyan
    Xu, Chongrui
    Wang, Zhen
    Liu, Ying
    Xin, Ying
    Lou, Haizhou
    Wang, Wei
    Chin, Kevin
    Li, Dandan
    Zhao, Di
    Gao, Yanfei
    Xu, Wenping
    Pan, Hongming
    [J]. FUTURE ONCOLOGY, 2022,
12345